<?xml version="1.0" encoding="UTF-8"?>
<p>We evaluated 168 patients using bDMARDs and 56 household controls with a mean age of 50.15 years (±13.92) and 48.47 (±16.85), respectively (
 <italic>p</italic>=0.314). Female sex corresponded to 67% of the cases in the group using bDMARDs, which was more frequent than in the controls, with 52% females, but the difference was not statistically significant (
 <italic>p</italic>=0.055). The presence of comorbidities was observed in 80% of the group of patients using bDMARDs and in 57% of the control group (
 <italic>p</italic>=0.001).
</p>
